A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research

Medical Care

Volumn 48, Issue 8, 2010, Pages 710-717

  Fang, Gang ^a   Brooks, John M ^a   Chrischilles, Elizabeth A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

comparative effectiveness research; geographic variation; instrumental variable; practice style; treatment variation

Indexed keywords

THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG CHOICE; ESSENTIAL HYPERTENSION; FEMALE; GEOGRAPHY; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PHYSICIAN; PREDICTOR VARIABLE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; COMPARATIVE EFFECTIVENESS RESEARCH; DRUG UTILIZATION; FEMALE; HUMANS; HYPERTENSION; IOWA; MALE; MEDICAID; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; POVERTY; RETROSPECTIVE STUDIES; SMALL-AREA ANALYSIS; SODIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 77954954829     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181e41bb2     Document Type: Article

References (47)

1. Congressional Budget Office. Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role. Washington, DC: The Congress of the United States; 2007. Report No.: 2975
2. The Brookings Institution. Implementing Comparative Effectiveness Research: Priorities, Methods, and Impact. Washington, DC: The Brookings Institution; 2009.
3. Orszag PR. "Health costs are the real deficit threat." Wall Str J. 2009:A13.
4. Wennberg J. Which rate is right? N Engl J Med. 1986;314:310-311.
5. Yin W, Basu A, Zhang JX, et al. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148:169-177.
6. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007;26:1735-1744.
7. Brookhart MA, Wang PS, Solomon DH, et al. Instrumental variable analysis of secondary pharmacoepidemiologic data. Epidemiology. 2006;17:373-374.
8. Brooks JM, Chrischilles EA. Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods. Med Care. 2007;45:S123-S130.
9. Brooks JM, Chrischilles EA, Scott SD, et al. Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa. Health Serv Res. 2003;38:1385-1402.
10. Harris KM, Remler DK. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res. 1998;33:1337-1360.
11. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272:859-866.
12. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34.
13. Park TR, Brooks JM, Chrischilles EA, et al. Estimating the effect of treatment rate changes when treatment benefits are heterogeneous: antibiotics and otitis media. Value Health. 2008;11:304-314.
14. Stukel TA, Fisher ES, Wennberg DE, et al. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007;297:278-285.
15. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444-455.
16. Heckman JJ, Vytlacil EJ. Local instrumental variables and latent variable models for identifying and bounding treatment effects. Proc Natl Acad Sci USA. 1999;96:4730-4734.
17. Imbens GW, Angrist JD. Identification and estimation of local average treatment effects. Econometrica. 1994;62:467-475.
18. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:1102.
19. Angrist JD, Krueger AB. Instrumental variables and the search for identification: from supply and demand to natural experiments. J Econ Perspect. 2001;15:69-85.
20. Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica. 1997;65:557-586.
21. Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology. 2006;17:260-267.
22. Shea J. Instrument relevance in multivariate linear models: a simple measure. Rev Econ Stat. 1997;79:348-352.
23. Novikov I, Kalter-Leibovici O. Analytic approaches to observational studies with treatment selection bias. JAMA. 2007;297:2077.
24. Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endo-geneous explanatory variable is weak. J Am Stat Assoc. 1995;90:443-450.
25. Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17:268-275.
26. Rassen JA, Brookhart MA, Glynn RJ, et al. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol. 2009;62:1233-1241.
27. Brookhart MA, Rassen JA, Wang PS, et al. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care. 2007;45:S116-S122.
28. Hennessy S, Leonard CE, Palumbo CM, et al. Instantaneous preference was a stronger instrumental variable than 3-and 6-month prescribing preference for NSAIDs. J Clin Epidemiol. 2008;61:1285-1288.
29. Lu-Yao GL, Albertsen PC, Moore DF, et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008;300:173-181.
30. Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340:32-39.
31. Diehr P, Cain KC, Kreuter W, et al. Can small-area analysis detect variation in surgery rates? The power of small-area variation analysis. Med Care. 1992;30:484-502.
32. Fisher ES, Bynum JP, Skinner JS. Slowing the growth of health care costs\lessons from regional variation. N Engl J Med. 2009;360:849-852.
33. Phelps CE. Diffusion of information in medical care. J Econ Perspect. 1992;6:23-42.
34. Wennberg JE. Dealing with medical practice variations: a proposal for action. Health Aff (Millwood). 1984;3:6-32.
35. Phelps CE, Parente ST. Priority setting in medical technology and medical practice assessment. Med Care. 1990;28:703-723.
36. Wennberg JE. On patient need, equity, supplier-induced demand, and the need to assess the outcome of common medical practices. Med Care. 1985;23:512-520.
37. Dartmouth Medical School. The Dartmouth Atlas of Health Care in the United States. Chicago, IL: American Hospital Publishing; 1999.
38. Wennberg J, Gittelsohn. Small area variations in health care delivery. Science. 1973;182:1102-1108.
39. Goodman DC, Mick SS, Bott D, et al. Primary care service areas: a new tool for the evaluation of primary care services. Health Serv Res. 2003;38:287-309.
40. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group; The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288:2981-2997.
41. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
42. O'Connor GT, Quinton HB, Traven ND, et al. Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA. 1999;281:627-633.
43. The Centers for Medicare & Medicaid Services. Chronic Condition Data Warehouse User Manual. Baltimore, MD: The Centers for Medicare & Medicaid Services; 2009. Available at: http://www.ccwdata.org. Accessed August 11, 2009.
44. Garnick DW, DeLong ER, Luft HS. Measuring hospital mortality rates: are 30-day data enough? Ischemic Heart Disease Patient Outcomes Research Team. Health Serv Res. 1995;29:679-695.
45. Leibson CL, Naessens JM, Brown RD, et al. Accuracy of hospital discharge abstracts for identifying stroke. Stroke. 1994;25:2348-2355.
46. Hogarty KY, Ferron JM, Hess MR, et al. A macro for computing point estimates and confidence intervals for mahalanobis distance. In: SAS Users Group International; April 10-13, 2005; Philadelphia, PA.
47. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. 1st ed. Boca Raton, FL: Chapman & Hall/CRC; 1994.